Vanda Pharmaceuticals
VNDA
#8311
Rank
โ‚ฌ0.28 B
Marketcap
4,77ย โ‚ฌ
Share price
2.39%
Change (1 day)
22.67%
Change (1 year)

Revenue for Vanda Pharmaceuticals (VNDA)

Revenue in 2026 (TTM): โ‚ฌ0.18 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.18 Billion. In 2025 the company made a revenue of โ‚ฌ0.18 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ0.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vanda Pharmaceuticals from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.18 B1.08%
2025 โ‚ฌ0.18 B-3.69%
2024 โ‚ฌ0.19 B9.61%
2023 โ‚ฌ0.17 B-26.52%
2022 โ‚ฌ0.23 B-0.04%
2021 โ‚ฌ0.23 B17.59%
2020 โ‚ฌ0.20 B-0.51%
2019 โ‚ฌ0.20 B20.14%
2018 โ‚ฌ0.16 B22.69%
2017 โ‚ฌ0.13 B-0.89%
2016 โ‚ฌ0.13 B38.08%
2015 โ‚ฌ0.10 B143.78%
2014 โ‚ฌ41.23 M68.11%
2013 โ‚ฌ24.53 M-0.85%
2012 โ‚ฌ24.74 M2.75%
2011 โ‚ฌ24.07 M-10.31%
2010 โ‚ฌ26.84 M745.76%
2009 โ‚ฌ3.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ82.50 B 44,147.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.44 B 25,879.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ54.20 B 28,972.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ61.86 B 33,075.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ56.31 B 30,099.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.51 B 22,162.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA